Bosentan (Tracleer) for pulmonary arterial hypertension

被引：0
|
作者：
不详
机构：
来源：
MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 2002年 / 44卷 / 1127期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：30 / 32
页数：3
相关论文
共 50 条
  • [41] Pulmonary arterial hypertension: Patient transition from epoprostenol to bosentan
    Bshouty, Z
    Da Ponte, FM
    CHEST, 2003, 124 (04) : 89S - 89S
  • [42] Experience with bosentan in pulmonary arterial hypertension secondary to systemic sclerosis
    Caroline Barranco
    Nature Clinical Practice Rheumatology, 2006, 2 (4): : 181 - 181
  • [43] Bosentan improves pulmonary microvascular endothelial function in adults with pulmonary arterial hypertension
    Ilsar, R.
    Levitt, J.
    Adams, M. R.
    Celermajer, D. S.
    EUROPEAN HEART JOURNAL, 2009, 30 : 110 - 110
  • [44] Bosentan for pulmonary hypertension
    Dietrich, CG
    Geier, A
    Lammert, F
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (04): : 292 - 293
  • [45] Comparison of the effects of bosentan on endothelial function in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension
    Hirashiki, A.
    Kamimura, Y.
    Nakano, Y.
    Adachi, S.
    Takeshita, K.
    Murohara, T.
    Kondo, T.
    EUROPEAN HEART JOURNAL, 2015, 36 : 455 - 456
  • [46] Effect of Bosentan on Exercise Capacity in Patients with Pulmonary Arterial Hypertension or Inoperable Chronic Thromboembolic Pulmonary Hypertension
    Hirashiki, Akihiro
    Kondo, Takahisa
    Nakano, Yoshihisa
    Adachi, Shiro
    Okumura, Takahiro
    Murohara, Toyoaki
    JOURNAL OF CARDIAC FAILURE, 2013, 19 (10) : S145 - S145
  • [47] Effects of bosentan on peripheral endothelial function in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension
    Hirashiki, Akihiro
    Adachi, Shiro
    Nakano, Yoshihisa
    Kamimura, Yoshihiro
    Shimokata, Shigetake
    Takeshita, Kyosuke
    Murohara, Toyoaki
    Kondo, Takahisa
    PULMONARY CIRCULATION, 2016, 6 (02) : 168 - 173
  • [48] Bosentan use in systemic lupus erythematosus patients with pulmonary arterial hypertension
    Mok, M. Y.
    Tsang, P. L.
    Lam, Y. M.
    Lo, Y.
    Wong, W. S.
    Lau, C. S.
    LUPUS, 2007, 16 (04) : 279 - 285
  • [49] Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertension
    Barst, RJ
    Ivy, D
    Dingemanse, J
    Widlitz, A
    Schmitt, K
    Doran, A
    Bingaman, D
    Nguyen, N
    Gaitonde, M
    van Giersbergen, PLM
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (04) : 372 - 382
  • [50] Effectiveness of bosentan in a case of pulmonary arterial hypertension associated with myelodysplastic syndrome
    Luis Gamez-Lopez, Antonio
    Luis Bonilla-Palomas, Juan
    Moreno-Conde, Mirian
    Cristina Lopez-Ibanez, Maria
    Villar-Raez, Antonia
    ANNALS OF HEMATOLOGY, 2014, 93 (05) : 883 - 884
12345